ArticleHemaSphere2023

Ixazomib-Thalidomide-Dexamethasone Induction Followed by Ixazomib or Placebo Maintenance in Nontransplant Eligible Newly Diagnosed Multiple Myeloma Patients: Long-term Results of HOVON-126/NMSG 21.13.

Kazimierz Groen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.